The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Disease-Induced Skeletal Muscle Atrophy and Fatigue
Open accessAbstract
Numerous health problems, including acute critical illness, cancer, diseases associated with chronic inflammation, and neurological disorders, often result in skeletal muscle weakness and fatigue. Disease-related muscle atrophy and fatigue is an important clinical problem because acquired skeletal muscle weakness can increase the duration of hospitalization, result in exercise limitation, and contribute to a poor quality of life. Importantly, skeletal muscle atrophy is also associated with increased morbidity and mortality of patients. Therefore, improving our understanding of the mechanism(s) responsible for skeletal muscle weakness and fatigue in patients is a required first step to develop clinical protocols to prevent these skeletal muscle problems. This review will highlight the consequences and potential mechanisms responsible for skeletal muscle atrophy and fatigue in patients experiencing acute critical illness, cancer, chronic inflammatory diseases, and neurological disorders.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive versus Conventional Glucose Control in Critically Ill Patients
(2009) · New England Journal of Medicine · doi:10.1056/nejmoa0810625 · Cited by 5,119
Tumors: Wounds That Do Not Heal
Flier, J. S., Underhill, L. H., & Dvorak, H. F. (1986) · New England Journal of Medicine · doi:10.1056/nejm198612253152606 · Cited by 4,391 · cited 1×
“Fn14 expression is increased after wounding, and it has been said that tumors resemble ‘‘wounds that do not heal’’ (28) with Fn14 present in high levels in solid tumors (20).”
BackgroundAcute skeletal muscle wasting in critical illness
Puthucheary, Z. A., Rawal, J., McPhail, M., Connolly, B., Ratnayake, G., Chan, P., Hopkinson, N. S., Padhke, R., Dew, T., Sidhu, P. S., et al. (2013) · JAMA · doi:10.1001/jama.2013.278481 · Cited by 2,103
Double muscling in cattle due to mutations in the myostatin gene
McPherron, A. C., & Lee, S.-J. (1997) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.94.23.12457 · Cited by 2,039
Cancer-related fatigue—mechanisms, risk factors, and treatments
Bower, J. E. (2014) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2014.127 · Cited by 1,666
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy
Kluger, B. M., Krupp, L. B., & Enoka, R. M. (2013) · Neurology · doi:10.1212/wnl.0b013e31827f07be · Cited by 1,036
The impact of fatigue on patients with multiple sclerosis
Fisk, J. D., Pontefract, A., Ritvo, P. G., Archibald, C. J., & Murray, T. J. (1994) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100048691 · Cited by 1,025 · cited 1×
“(37,50), 70% of patients with multiple sclerosis define fatigue as one of their worst symptoms (39,52), and more than 70% of people with traumatic brain injury report increased levels of fatigue (15,38).”
BackgroundCancer-related fatigue: the scale of the problem
Hofman, M., Ryan, J. L., Figueroa-Moseley, C. D., Jean-Pierre, P., & Morrow, G. R. (2007) · The Oncologist · doi:10.1634/theoncologist.12-s1-4 · Cited by 895
Clinical review: intensive care unit acquired weakness
Hermans, G., & Van den Berghe, G. (2015) · Critical Care · doi:10.1186/s13054-015-0993-7 · Cited by 792
Hermans, G., Wilmer, A., Meersseman, W., Milants, I., Wouters, P. J., Bobbaers, H., Bruyninckx, F., & Van den Berghe, G. (2007) · American Journal of Respiratory and Critical Care Medicine · doi:10.1164/rccm.200605-665oc · Cited by 368
Cited by
Tuttle, C. S. L., Thang, L. A. N., & Maier, A. B. (2020) · Ageing Research Reviews · doi:10.1016/j.arr.2020.101185 · Cited by 650
Biomarkers shared by frailty and sarcopenia in older adults: A systematic review and meta-analysis
Picca, A., Coelho-Junior, H. J., Calvani, R., Marzetti, E., & Vetrano, D. L. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101530 · Cited by 368
Amelioration of muscle wasting by glucagon‐like peptide‐1 receptor agonist in muscle atrophy
Hong, Y., Lee, J. H., Jeong, K. W., Choi, C. S., & Jun, H. (2019) · Journal of Cachexia, Sarcopenia and Muscle · doi:10.1002/jcsm.12434 · Cited by 188
“and increases mortality and morbidity.(6) Thus, the demand for the development of specialized medicine for muscle atrophy has been increasing and becoming an important research topic worldwide.”
BackgroundYamada, M., Iwata, M., Warabi, E., Oishi, H., Lira, V. A., & Okutsu, M. (2019) · The FASEB Journal · doi:10.1096/fj.201900133r · Cited by 63
“, cancer, congestive heart failure, chronic kidney disease, and chronic obstructive pulmonary disease) that contribute to morbidity and mortality (1).”
BackgroundBaek, S., Kim, J., Moon, B. S., Park, S. M., Jung, D. E., Kang, S. Y., Lee, S. J., Oh, S. J., Kwon, S. H., Nam, M. H., et al. (2020) · Nutrients · doi:10.3390/nu12123731 · Cited by 39
Metadata
- Authors
- POWERS, S. K., LYNCH, G. S., MURPHY, K. T., REID, M. B., & ZIJDEWIND, I.
- Venue
- Medicine & Science in Sports & Exercise
- Published
- 2016-11
- Volume
- 48
- Issue
- 11
- Pages
- 2307-2319
- ISSN
- 0195-9131 (ISSN-L)
- OpenAlex
- W2342422779
- Cited by
- 216
- References
- 17
- FWCI
- 5.42
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Disease-Induced Skeletal Muscle Atrophy and Fatigue. https://app.cochat.ai/papers/10.1249/mss.0000000000000975
- The paper
- POWERS, S. K., LYNCH, G. S., MURPHY, K. T., REID, M. B., & ZIJDEWIND, I. (2016). Disease-Induced Skeletal Muscle Atrophy and Fatigue. Medicine & Science in Sports & Exercise. https://doi.org/10.1249/mss.0000000000000975
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.